Experimental Study on Laminar Burning Characteristics of Premixed 2,5-Dimethylfuran/Air Mixtures at Elevated Pressures and Temperatures.

Experimental studies of laminar burning velocity and flame instabilities of 2,5-dimethylfuran (DMF) were conducted at different equivalence ratios (from 0.9 to 1.3), initial pressures (from 0.1 to 0.8 MPa), and initial temperatures (from 393 to 493 K) by the method of the schlieren and high-speed photography system in the constant-volume combustion bomb. The results showed that the laminar burning velocity of the DMF/air flame decreased with increasing initial pressure and increased with increasing initial temperature. The maximum laminar burning velocity occurred at φ = 1.1, regardless of the initial pressure and temperature conditions. The power law fitting of baric coefficients, thermal coefficients, and laminar burning velocity was obtained, and the laminar burning velocity of DMF/air flame can be predicted well in the study range. The diffusive-thermal instability of the DMF/air flame was more pronounced during rich combustion. Increasing the initial pressure increased both the diffusive-thermal instability and the hydrodynamic instability of the flame, while increasing the initial temperature increased the diffusive-thermal instability of the flame, which was mainly responsible for flame propagation. In addition, the Markstein length, density ratio, flame thickness, critical radius, acceleration index, and classification excess of the DMF/air flame were investigated. The results of this paper provide a theoretical support for the application of DMF in engineering.

A calculation method and experiment study of high-pressure common rail injection rate with solenoid injectors.

The high-pressure common rail system has been widely used owing to its precise control of fuel injection rate profile, which plays a decisive role in cylinder combustion, atomization, and emission. The fuel injection rate profile of high-pressure common rail system was studied, and a fuel injection rate profile calculation model is proposed. The model treats the injector as a black box. Some measured data are needed to calculate the parameters in the model. The rise and fall of injection rate is regarded as trigonometric function to reduce the complexity and increase the accuracy. The model was verified using two different types of fuel injectors. The model calculation results were evaluated under various data input conditions. The results show that the model has good applicability to different input data and injectors. In addition, because the model building requires a large amount of experimental data, a comprehensive analysis of various input data was also conducted. The injection profile was analyzed from a new perspective and the regularity of injection rate profile was established.

Experiment investigation of injection parameters effects on injection stability of a high pressure common rail system.

High pressure common rail system can precisely control the injection time and injection pressure to improve the thermal efficiency of the engine. The injection characteristics of the system can affect the combustion and emission process of the engine. Injection stability is defined as variation characteristics of injection. This could have an unignored influence on combustion and engine output, while few study has been published. The primary objective is to establish evaluation systems and methods for injection stability. Then to study injection stability of the high pressure common rail system. Firstly, several parameters that have an important influence on the emission and combustion are identified. Based on the characteristics data obtained, it is verified that the stability parameters are in accordance with the normal distribution. Then, the five characteristic stability parameters of close speed of injection, cycle injection mass, injection delay, maximum injection rate and open speed of injection were quantitatively analyzed by using range, relative range, kurtosis and variance. It is found that the close speed of injection is greatly depend on injection pressure, the range of close speed varies from 1.8 to 5.1 mg/ms when rail pressure varies from 60 MPa to 160 MPa at 0.6 ms energizing time. The stability of injection mass depends on energizing time, the relative range in short energizing time can be four times than long energizing time. The maximum injection rate has similar characteristics with injection mass, it is also depends on energizing time. The range of maximum injection rate is reduced from the average of 0.6-0.7 mg/ms to 0.3 or even 0.2 mg/ms with the increase of energizing time. The injection delay and open speed of injection seems to be greatly affected by pressure fluctuation, since the observed data present complex rules. Pressure fluctuation in common rail can affect injection stability a lot.

Preclinical Pharmacokinetics, Tissue Distribution, and Plasma Protein Binding of Sodium (±)-5-Bromo-2-(α-Hydroxypentyl) Benzoate (BZP), an Innovative Potent Anti-ischemic Stroke Agent.

Sodium (±)-5-bromo-2-(α-hydroxypentyl) benzoate (BZP) is a potential cardiovascular drug and exerts potent neuroprotective effect against transient and long-term ischemic stroke in rats. BZP could convert into 3-butyl-6-bromo-1(3H)-isobenzofuranone (Br-NBP) in vitro and in vivo. However, the pharmacokinetic profiles of BZP and Br-NBP still have not been evaluated. For the purpose of investigating the pharmacokinetic profiles, tissue distribution, and plasma protein binding of BZP and Br-NBP, a rapid, sensitive, and specific method based on liquid chromatography coupled to mass spectrometry (LC-MS/MS) has been developed for determination of BZP and Br-NBP in biological samples. The results indicated that BZP and Br-NBP showed a short elimination half-life, and pharmacokinetic profile in rats (3, 6, and 12 mg/kg; i.v.) and beagle dogs (1, 2, and 4 mg/kg; i.v.gtt) were obtained after single dosing of BZP. After multiple dosing of BZP, there was no significant accumulation of BZP and Br-NBP in the plasma of rats and beagle dogs. Following i.v. single dose (6 mg/kg) of BZP to rats, BZP and Br-NBP were distributed rapidly into all tissues examined, with the highest concentrations of BZP and Br-NBP in lung and kidney, respectively. The brain distribution of Br-NBP in middle cerebral artery occlusion (MCAO) rats was more than in normal rats (P < 0.05). The plasma protein binding degree of BZP at three concentrations (8000, 20,000, and 80,000 ng/mL) from rat, beagle dog, and human plasma were 98.1-98.7, 88.9-92.7, and 74.8-83.7% respectively. In conclusion, both BZP and Br-NBP showed short half-life, good dose-linear pharmacokinetic profile, wide tissue distribution, and different degree protein binding to various species plasma. This was the first preclinical pharmacokinetic investigation of BZP and Br-NBP in both rats and beagle dogs, which provided vital guidance for further preclinical research and the subsequent clinical trials.

LC-MS/MS Analysis and Pharmacokinetics of Sodium (±)-5-Bromo-2-(α-hydroxypentyl) Benzoate (BZP), an Innovative Potent Anti-Ischemic Stroke Agent in Rats.

A rapid, sensitive and selective liquid chromatography-triple quadrupole mass spectrometry (LC-MS/MS) method was developed and validated for the simultaneous determination of sodium (±)-5-Bromo-2-(α-hydroxypentyl) benzoate (BZP) and its active metabolite 3-butyl-6-bromo-1(3H)-isobenzofuranone (Br-NBP) in rat plasma using potassium 2-(1-hydroxypentyl)-benzoate (PHPB) and l-3-n-butylphthalide (NBP) as internal standards (IS). Chromatographic separation was achieved on a Hypersil GOLD C18 column using a gradient elution of ammonium acetate and methanol at a flow rate of 0.2 mL/min. Good linearity was achieved within the wide concentration range of 5-10,000 ng/mL. The intra-day and inter-day precision was less than 8.71% and the accuracy was within -8.53% and 6.38% in quality control and the lower limit of quantitation samples. BZP and Br-NBP were stable during the analysis and the storage period. The method was successfully applied to pharmacokinetic studies of BZP in Sprague-Dawley rats for the first time. After a single intravenous administration of BZP at the dose of 0.75 mg/kg, the plasma concentration of BZP and Br-NBP declined rapidly and the AUC0-t of BZP was significantly greater in female rats compared to male rats (p < 0.05). The data presented in this study serve as a firm basis for further investigation of BZP in both preclinical and clinical phases.

Content and activity of human liver microsomal protein and prediction of individual hepatic clearance in vivo.

The lack of information concerning individual variation in content and activity of human liver microsomal protein is one of the most important obstacles for designing personalized medicines. We demonstrated that the mean value of microsomal protein per gram of liver (MPPGL) was 39.46 mg/g in 128 human livers and up to 19-fold individual variations existed. Meanwhile, the metabolic activities of 10 cytochrome P450 (CYPs) were detected in microsomes and liver tissues, respectively, which showed huge individual variations (200-fold). Compared with microsomes, the activities of liver tissues were much suitable to express the individual variations of CYP activities. Furthermore, individual variations in the in vivo clearance of tolbutamide were successfully predicted with the individual parameter values. In conclusion, we offer the values for MPPGL contents in normal liver tissues and build a new method to assess the in vitro CYP activities. In addition, large individual variations exist in predicted hepatic clearance of tolbutamide. These findings provide important physiological parameters for physiologically-based pharmacokinetics models and thus, establish a solid foundation for future development of personalized medicines.

Contribution of baicalin on the plasma protein binding displacement and CYP3A activity inhibition to the pharmacokinetic changes of nifedipine in rats in vivo and in vitro.

Baicalin purified from the root of Radix scutellariae is widely used in clinical practices. This study aimed to evaluate the effect of baicalin on the pharmacokinetics of nifedipine, a CYP3A probe substrate, in rats in vivo and in vitro. In a randomised, three-period crossover study, significant changes in the pharmacokinetics of nifedipine (2 mg/kg) were observed after treatment with a low (0.225 g/kg) or high (0.45 g/kg) dose of baicalin in rats. In the low- and high-dose groups of baicalin-treated rats, C max of total nifedipine decreased by 40%±14% (P<0.01) and 65%±14% (P<0.01), AUC0-∞ decreased by 41%±8% (P<0.01) and 63%±7% (P<0.01), Vd increased by 85%±43% (P<0.01) and 224%±231% (P<0.01), and CL increased by 97%±78% (P<0.01) and 242%±135% (P<0.01), respectively. Plasma protein binding experiments in vivo showed that C max of unbound nifedipine significantly increased by 25%±19% (P<0.01) and 44%±29% (P<0.01), respectively, and there was a good correlation between the unbound nifedipine (%) and baicalin concentrations (P<0.01). Furthermore, in vitro results revealed that baicalin was a competitive displacer of nifedipine from plasma proteins. In vitro incubation experiments demonstrated that baicalin could also competitively inhibit CYP3A activity in rat liver microsomes in a concentration-dependent manner. In conclusion, the pharmacokinetic changes of nifedipine may be modulated by the inhibitory effects of baicalin on plasma protein binding and CYP3A-mediated metabolism.

[Study on the effects of lead from small industry of battery recycling on environment and children's health].

OBJECTIVE: In order to minimize lead pollution and to protect the identified individuals with high blood lead level from lead contamination, an epidemiological study was carried on children living around the village and township-owned lead industries in Tianying town. METHODS: Environmental monitoring: lead levels in air, soil, drinking water and crops were measured. Biological monitoring: 959 children aged 5 - 12 years were selected from villages where the lead smelters located near the residential areas and the battery disassembling was done in some families. The control children (207 pupils) were from other villages without lead exposure. Blood lead, ZnPP and teeth lead were determined. Height, weight and head circle of children and IQ scores were measured. RESULTS: The environment was seriously polluted. The average lead concentrations in air and soils were 8.5 times and 10 times of the MACs (national health standard) respectively. Eighty-five per cent the air samples with lead concentrations higher than the national health standard. Local crops and wheat at farmers' home were also contaminated by lead dust, with. Lead content being 24 times higher than the standard. The mean blood lead and ZnPP levels of children lived in the polluted areas were 496 microgram/L and 9.41 microgram/g Hb respectively. The lead exposure caused adverse effects on children's IQ and physical development. CONCLUSION: It is necessary to remove and reduce currently active sources of lead pollution in the community and to increase public awareness of potential health effects of lead exposure.